Groove Botanicals, Inc. Logo

Groove Botanicals, Inc.

GRVE

(2.2)
Stock Price

0,00 USD

-5287.59% ROA

20.5% ROE

-1.99x PER

Market Cap.

322.073,00 USD

0% DER

0% Yield

0% NPM

Groove Botanicals, Inc. Stock Analysis

Groove Botanicals, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Groove Botanicals, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (29.36%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 PBV

The stock's low PBV ratio (-1.27x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (-17%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

5 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

6 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

7 ROA

The stock's ROA (-72.19%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Groove Botanicals, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Groove Botanicals, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Sell

Groove Botanicals, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Groove Botanicals, Inc. Revenue
Year Revenue Growth
1994 300.000
1995 300.000 0%
1996 800.000 62.5%
1997 900.000 11.11%
2001 134.963 -566.85%
2002 48.898 -176.01%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 49.671 100%
2008 249.856 80.12%
2009 320.712 22.09%
2010 262.660 -22.1%
2011 187.913 -39.78%
2012 253.882 25.98%
2013 163.574 -55.21%
2014 156.322 -4.64%
2015 110.371 -41.63%
2016 52.933 -108.51%
2017 57.021 7.17%
2018 114.536 50.22%
2019 16.386 -598.99%
2020 5.034 -225.51%
2021 2.335 -115.59%
2022 8.052 71%
2023 1.180 -582.37%
2024 0 0%
2025 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Groove Botanicals, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1994 0
1995 0 0%
1996 0 0%
1997 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%
2025 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Groove Botanicals, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1994 0
1995 0 0%
1996 0 0%
1997 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 1.676.232 100%
2010 924.779 -81.26%
2011 1.131.543 18.27%
2012 538.784 -110.02%
2013 0 0%
2014 0 0%
2015 309.988 100%
2016 788.836 60.7%
2017 0 0%
2018 114.176 100%
2019 0 0%
2020 0 0%
2021 325.343 100%
2022 289.607 -12.34%
2023 175.514 -65.01%
2024 266.581 34.16%
2025 146.156 -82.39%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Groove Botanicals, Inc. EBITDA
Year EBITDA Growth
1994 -900.000
1995 -1.800.000 50%
1996 -2.900.000 37.93%
1997 -3.500.000 17.14%
2001 -5.094.323 31.3%
2002 -914.985 -456.77%
2003 -148.601 -515.73%
2004 -280.573 47.04%
2005 -244.540 -14.74%
2006 -453.930 46.13%
2007 -1.304.553 65.2%
2008 -2.861.823 54.42%
2009 -1.358.490 -110.66%
2010 -106.029 -1181.24%
2011 -1.047.039 89.87%
2012 -410.877 -154.83%
2013 -495.434 17.07%
2014 -525.952 5.8%
2015 -814.284 35.41%
2016 -799.088 -1.9%
2017 -173.260 -361.21%
2018 -45.380 -281.8%
2019 7.640 693.98%
2020 -5.490 239.16%
2021 -399.220 98.62%
2022 -407.570 2.05%
2023 -175.510 -132.22%
2024 -266.580 34.16%
2025 -146.160 -82.39%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Groove Botanicals, Inc. Gross Profit
Year Gross Profit Growth
1994 100.000
1995 100.000 0%
1996 400.000 75%
1997 200.000 -100%
2001 -60.653 429.74%
2002 30.332 299.96%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 -4.647 100%
2008 99.720 104.66%
2009 248.742 59.91%
2010 141.479 -75.82%
2011 37.605 -276.22%
2012 125.011 69.92%
2013 38.672 -223.26%
2014 22.289 -73.5%
2015 10.311 -116.17%
2016 -82.727 112.46%
2017 -27.782 -197.77%
2018 59.376 146.79%
2019 9.094 -552.91%
2020 1.610 -464.84%
2021 379 -324.8%
2022 8.052 95.29%
2023 1.180 -582.37%
2024 0 0%
2025 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Groove Botanicals, Inc. Net Profit
Year Net Profit Growth
1994 -900.000
1995 -2.500.000 64%
1996 -2.900.000 13.79%
1997 -3.800.000 23.68%
2001 -5.820.739 34.72%
2002 -1.050.670 -454%
2003 98.537 1166.27%
2004 -300.367 132.81%
2005 -212.445 -41.39%
2006 -498.956 57.42%
2007 -3.440.222 85.5%
2008 -3.229.527 -6.52%
2009 -2.085.183 -54.88%
2010 -2.273.164 8.27%
2011 -1.316.251 -72.7%
2012 -737.154 -78.56%
2013 -749.314 1.62%
2014 -785.978 4.66%
2015 100.314 883.52%
2016 -2.503.835 104.01%
2017 -234.783 -966.45%
2018 -66.260 -254.34%
2019 6.497 1119.86%
2020 -5.185 225.3%
2021 -341.599 98.48%
2022 -290.458 -17.61%
2023 -120.726 -140.59%
2024 -202.089 40.26%
2025 -146.156 -38.27%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Groove Botanicals, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1994 -967
1995 -2.685 64.02%
1996 0 0%
1997 0 0%
2001 -6.252 100%
2002 -963 -549.22%
2003 60 1705%
2004 -48 225%
2005 -27 -77.78%
2006 -26 -8%
2007 -95 73.4%
2008 -44 -113.64%
2009 -11 -340%
2010 -6 -100%
2011 -1 -400%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%
2025 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Groove Botanicals, Inc. Free Cashflow
Year Free Cashflow Growth
1994 -800.000
1995 -2.500.000 68%
1996 -4.200.000 40.48%
1997 -3.500.000 -20%
2001 -1.126.809 -210.61%
2002 -345.094 -226.52%
2003 -177.518 -94.4%
2004 -125.181 -41.81%
2005 -37.971 -229.68%
2006 -208.566 81.79%
2007 -1.185.838 82.41%
2008 -1.792.302 33.84%
2009 -1.173.496 -52.73%
2010 -46.534 -2421.8%
2011 -701.250 93.36%
2012 -430.338 -62.95%
2013 -333.883 -28.89%
2014 -381.594 12.5%
2015 -373.000 -2.3%
2016 -348.922 -6.9%
2017 -103.646 -236.65%
2018 -249 -41524.9%
2019 0 0%
2020 0 0%
2021 -136.761 100%
2022 -72.905 -87.59%
2023 -115.403 36.83%
2024 -135.110 14.59%
2025 -20.744 -551.32%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Groove Botanicals, Inc. Operating Cashflow
Year Operating Cashflow Growth
1994 -700.000
1995 -2.300.000 69.57%
1996 -3.800.000 39.47%
1997 -3.100.000 -22.58%
2001 -1.116.414 -177.67%
2002 -342.383 -226.07%
2003 -177.518 -92.87%
2004 -125.181 -41.81%
2005 -37.971 -229.68%
2006 -207.190 81.67%
2007 -815.992 74.61%
2008 -1.080.401 24.47%
2009 -1.040.969 -3.79%
2010 -46.534 -2137.01%
2011 -701.250 93.36%
2012 -430.338 -62.95%
2013 -333.883 -28.89%
2014 -381.594 12.5%
2015 -230.343 -65.66%
2016 -348.922 33.98%
2017 -103.646 -236.65%
2018 -249 -41524.9%
2019 0 0%
2020 0 0%
2021 -136.761 100%
2022 -72.905 -87.59%
2023 -115.403 36.83%
2024 -135.110 14.59%
2025 -20.744 -551.32%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Groove Botanicals, Inc. Capital Expenditure
Year Capital Expenditure Growth
1994 100.000
1995 200.000 50%
1996 400.000 50%
1997 400.000 0%
2001 10.395 -3748%
2002 2.711 -283.44%
2003 0 0%
2004 0 0%
2005 0 0%
2006 1.376 100%
2007 369.846 99.63%
2008 711.901 48.05%
2009 132.527 -437.17%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 142.657 100%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%
2025 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Groove Botanicals, Inc. Equity
Year Equity Growth
1994 -900.000
1995 5.400.000 116.67%
1996 2.500.000 -116%
1997 2.200.000 -13.64%
2001 -1.605.318 237.04%
2002 -1.678.181 4.34%
2003 -524.274 -220.1%
2004 -655.141 19.98%
2005 -457.112 -43.32%
2006 -54.969 -731.58%
2007 2.761.598 101.99%
2008 2.461.896 -12.17%
2009 2.762.090 10.87%
2010 945.680 -192.07%
2011 1.046.928 9.67%
2012 587.993 -78.05%
2013 442.088 -33%
2014 1.212.337 63.53%
2015 1.690.152 28.27%
2016 -598.841 382.24%
2017 -1.000.351 40.14%
2018 -1.316.672 24.02%
2019 -1.323.605 0.52%
2020 -1.429.610 7.41%
2021 -522.526 -173.6%
2022 -454.935 -14.86%
2023 -438.298 -3.8%
2024 -760.557 42.37%
2025 -851.713 10.7%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Groove Botanicals, Inc. Assets
Year Assets Growth
1994 300.000
1995 5.700.000 94.74%
1996 2.800.000 -103.57%
1997 2.700.000 -3.7%
2001 69.153 -3804.39%
2002 30.511 -126.65%
2003 15.888 -92.04%
2004 748 -2024.06%
2005 51 -1366.67%
2006 45.142 99.89%
2007 2.993.201 98.49%
2008 2.734.501 -9.46%
2009 4.252.562 35.7%
2010 2.475.222 -71.81%
2011 2.700.632 8.35%
2012 2.615.260 -3.26%
2013 2.566.021 -1.92%
2014 2.731.243 6.05%
2015 2.747.257 0.58%
2016 373.628 -635.29%
2017 325.220 -14.88%
2018 295.817 -9.94%
2019 196.437 -50.59%
2020 196.437 0%
2021 57.911 -239.2%
2022 48.785 -18.71%
2023 5.048 -866.42%
2024 2.142 -135.67%
2025 3.054 29.86%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Groove Botanicals, Inc. Liabilities
Year Liabilities Growth
1994 1.200.000
1995 300.000 -300%
1996 300.000 0%
1997 500.000 40%
2001 1.674.471 70.14%
2002 1.708.692 2%
2003 540.162 -216.33%
2004 655.889 17.64%
2005 457.163 -43.47%
2006 100.111 -356.66%
2007 231.603 56.77%
2008 272.605 15.04%
2009 1.490.472 81.71%
2010 1.529.542 2.55%
2011 1.653.704 7.51%
2012 2.027.267 18.43%
2013 2.123.933 4.55%
2014 1.518.906 -39.83%
2015 1.057.105 -43.69%
2016 921.448 -14.72%
2017 1.192.458 22.73%
2018 1.424.548 16.29%
2019 1.520.042 6.28%
2020 1.626.047 6.52%
2021 580.438 -180.14%
2022 503.719 -15.23%
2023 443.346 -13.62%
2024 762.699 41.87%
2025 854.767 10.77%

Groove Botanicals, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-1.99x
Price To Sales Ratio
0x
POCF Ratio
-2.57
PFCF Ratio
-2.57
Price to Book Ratio
-0.38
EV to Sales
0
EV Over EBITDA
-1.4
EV to Operating CashFlow
-2.55
EV to FreeCashFlow
-2.55
Earnings Yield
-0.5
FreeCashFlow Yield
-0.39
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.03
Graham NetNet
-0.01

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.78
ROE
0.22
Return On Assets
-14.73
Return On Capital Employed
0.25
Net Income per EBT
1
EBT Per Ebit
0.7
Ebit per Revenue
0
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.27
Return on Tangible Assets
-52.88
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,01
Tangible Book Value per Share
-0.01
Shareholders Equity per Share
-0.01
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.01
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-851713
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Groove Botanicals, Inc. Dividends
Year Dividends Growth

Groove Botanicals, Inc. Profile

About Groove Botanicals, Inc.

Groove Botanicals, Inc. focuses on developing EV battery technologies. The company was formerly known as Avalon Oil & Gas, Inc. and changed its name to Groove Botanicals, Inc. in May 2018. Groove Botanicals, Inc. was incorporated in 1991 and is based in Minneapolis, Minnesota.

CEO
Mr. Kent A. Rodriguez
Employee
1
Address
310 Fourth Avenue South
Minneapolis, 55415

Groove Botanicals, Inc. Executives & BODs

Groove Botanicals, Inc. Executives & BODs
# Name Age
1 Mr. Kent A. Rodriguez
Chairman, Chief Executive Officer, President, Chief Financial Officer, Treasurer & Secretary
70
2 Mr. Menno Wiebe B. Sc. (Geol), MBA
Advisor
70

Groove Botanicals, Inc. Competitors